¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"serum thrombotic accelerator"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® linear accelerator ÇÑ±Û ¼±»ó°¡¼Ó±â
¼³¸í   
  Ä¡·á¹æ»ç¼±°ú¿¡¼­ ÀÌ¿ëÇϴ ±â°è·Î¼­ ÀüÀÚ¸¦ »ý¼ºÇØ ³½´Ù. ÀüÀڴ ´Ü¼øÈ÷ X-¼±°ú´Â ´Ù¸¥ °ÍÀ¸·Î ÀüÀÚ°¡ ±Ý¼Ó¿¡ ºÎµúÇô ³ª¿À´Â °ÍÀÌ X-¼±ÀÌ´Ù. ÀüÀڴ Áø´Ü¸ñÀûº¸´Ù´Â Ä¡·á¸ñÀûÀ¸·Î ÁַΠÇǺÎÀÇ ¾Ç¼ºÁ¾¾ç(¾Ï)¿¡ »ç¿ëµÈ´Ù.
¿µ¹® serum ÇÑ±Û Ç÷û
¼³¸í   
  Ç÷¾×ÀÇ ¼ººÐ Áß °íÇü¼ººÐÀΠÇ÷±¸¼¼Æ÷(ÀûÇ÷±¸, ¹éÇ÷±¸ µî), Ç÷¼ÒÆÇÀ» Á¦¿ÜÇÑ ºÎºÐÀ» Ç÷ÀåÀ̶ó°í Çϰí, Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¸¦ Á¦¿ÜÇÑ ºÎºÐÀ» Ç÷ûÀ̶ó°í ÇÑ´Ù.
¿µ¹® serum proteins ÇÑ±Û Ç÷û´Ü¹é
¼³¸í   
  Ç÷û¿¡ Àִ ´Ü¹éÁúµéÀ» ÃÑĪÇϴ ¸»·Î, ¸é¿ª±Û·ÎºÒ¸°(¸é¿ªÇö»ó¿¡ °ü¿©Çϴ Ç×ü¸¦ Çü¼ºÇÔ), ¾ËºÎ¹Î, º¸Ã¼ ¹× ÀÀ°íÀÎÀÚ¿Í ¿©·¯ È¿¼ÒµéÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù.
¿µ¹® serum enzyme ÇÑ±Û Ç÷ûȿ¼Ò
¼³¸í   
  Ç÷û ³»¿¡ Æ÷ÇԵǾî Àִ ¿©·¯ °¡Áö È¿¼Ò¸¦ ÀÏÄ´ ¸»ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerator
    1. ÃËÁøÀÎÀÚ, ÃËÁøÁ¦ 2. °¡¼Ó±â
  • accelerator nerve
    ÃËÁø½Å°æ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • particle accelerator
    ÀÔÀÚ°¡¼Ó±â
  • reaction accelerator
    ¹ÝÀÀÃËÁøÁ¦
  • antilymphocytic serum
    Ç׸²ÇÁ±¸Ç÷û
  • antiplatelet serum
    Ç×Ç÷¼ÒÆÇÇ÷û
  • antirabies serum
    Ç×±¤°ßº´Ç÷û
  • antitetanic serum
    ÇׯĻódzÇ÷û
  • antithymocyte serum
    Ç×°¡½¿»ù¼¼Æ÷Ç÷û, Ç×Èä¼±¼¼Æ÷Ç÷û
  • antitoxic serum
    Ç×µ¶¼ÒÇ÷û
  • acute phase serum
    ±Þ¼º±âÇ÷û
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î³úô¼ö¾×/Ç÷ûºñ
  • allergenic serum
    ¾Ë·¹¸£±âÇ÷û
  • bovine serum albumin
    ¼ÒÇ÷û¾ËºÎ¹Î
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerator
    1. ÃËÁøÀÎÀÚ, ÃËÁøÁ¦, 2. °¡¼Ó±â
  • serum hepatitis
    Ç÷û°£¿°
  • serum
    Ç÷û
  • serum sickness
    Ç÷ûº´
  • serum typing
    Ç÷ûÇü°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerator
    ÃËÁøÀÎÀÚ, ÃËÁøÁ¦, °¡¼Ó±â
  • accelerator nerve
    ÃËÁø½Å°æ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • particle accelerator
    ÀÔÀÚ°¡¼Ó±â
  • reaction accelerator
    ¹ÝÀÀÃËÁøÃ¼
  • thrombotic crisis
    Ç÷Àü¹ßÀÛ
  • thrombotic endocarditis
    Ç÷Àü½É³»¸·¿°
  • thrombotic gangrene
    Ç÷Àü±«Àú
  • thrombotic glaucoma
    Ç÷Àü³ì³»Àå
  • thrombotic infarct
    Ç÷Àü°æ»ö
  • thrombotic microangiopathy
    Ç÷Àü¹Ì¼¼Ç÷°üº´Áõ
  • thrombotic purpura
    Ç÷ÀüÀÚ»ö¹Ý
  • thrombotic thrombocytopenic purpura
    Ç÷ÀüÀúÇ÷¼ÒÆÇÇ÷ÁõÀÚ»ö¹Ýº´
  • acute phase serum
    ±Þ¼º±âÇ÷û
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î³úô¼ö¾×Ç÷ûºñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • TTP=£¾thrombotic thrombocytopenic purpura
    Ç÷Àü¼º Ç÷¼ÒÆÇ°¨¼ÒÀÚ¹ÝÁõ.
  • accelerator
    ÃËÁøÀÎÀÚ(õµòäì×í­), ÃËÁøÁ¦
  • accelerator
    °¡¼Ó±â, ÃËÁøÁ¦
  • accelerator nerve
    ÃËÁø½Å°æ(õµòäãêÌè).
  • reaction accelerator
    ¹ÝÀÀÃËÁøÃ¼(Úãëë õµòäô÷).
  • Cattanis serum
    īŸ´Ï¾×.
  • Cattanis serum
    īŸ´Ï¾×.
  • Cattanis serum
    īŸ´Ï¾×.
  • Cherons serum
    »þ·Î¿ìÇ÷û.
  • Glutamine-oxaloacetic transaminase, serum
    ±Û·çŽ¿Á»ì¾Æ¼¼Æ®»ê Ʋ¶õ½º¾Æ¹Ì³ªÁ¦
  • Ham test=acidified serum test
    ÇÜ °Ë»ç, »ê¼ºÈ­Ç÷û¿ëÇ÷°Ë»ç
  • Loefflers coagulated serum medium
    ·ÚÇ÷¯ÀÀ°íÇ÷û»ç¸é¹èÁö
  • Loefflers serum slant
    ·ÚÇ÷¯ Ç÷û»ç¸é¹èÁö
  • Luton s serum
    ·çÅæÇ÷û.
  • RISA=£¾radioiodinated serum albumin
    ¹æ»ç¼±¿ä¿ÀµåÇ÷û¾ËºÎ¹Î.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerator
    °¡¼Ó±â, ÃËÁøÁ¦
  • accelerator
    ÃËÁøÀÎÀÚ(õµòäì×í­), ÃËÁøÁ¦
  • accelerator nerve
    ÃËÁø½Å°æ(õµòäãêÌè).
  • augmentor nerve =accelerator n.
    ÃËÁø½Å°æ.
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear accelerator
    ¼±Çü°¡¼Ó±â(¡­Ê¥áÜÐï).
  • particle accelerator
    ÀÔÀÚ°¡¼Ó±â
  • reaction accelerator
    ¹ÝÀÀÃËÁøÃ¼(Úãëë õµòäô÷).
  • endocarditis,nonbacterial thrombotic
    ºñ¼¼±Õ¼ºÇ÷ÀüÁõ(Þªá¬Ð¶àõ ï°ñø)
  • nonbacterial thrombotic endocarditis
    ºñ¼¼±Õ¼º Ç÷Àü¼º ½É³»¸·¿°(~úìîûàõãý Үدæú).
  • thrombocytopenic purpura,thrombotic
    Ç÷Àü¼º(úìîûàõ)
  • thrombotic crisis
    Ç÷Àü¹ßÁõ(úìîûÛ¡ñø)
  • thrombotic endocarditis
    Ç÷Àü¼º ½É³»¸·¿°(¡­àõãýҮدæú)
  • thrombotic gangrene
    Ç÷Àü¼º AÀú(¡­ÎÕîÅ)
  • thrombotic glaucoma
    Ç÷Àü³ì³»Àå
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • precursor of serum prothrombin conversion accelerator
    Ç÷û(úìôè)ÇÁ·ÎÆ®·Òºó Àüȯ°¡¼ÓÁ¦ Àü±¸¹°Áú(ï®üµÊ¥áÜð¥îñÏÌÚªòõ)
  • serum prothrombin conversion accelerator
    Ç÷û(úìôè) ÇÁ·ÎÆ®·Òºó ÀüȯÃËÁøÁ¦(ï®üµõµòäð¥)
  • accelerator
    °¡¼Ó±â (Ê¥áÜÐï)
  • accelerator globulin
    ÃËÁø (õµòä) ±Û·ÎºÒ¸°
  • accelerator protein
    ÃËÁø´Ü¹éÁú (õµòäÓ±ÛÜòõ)
  • linear accelerator
    ¼±Çü°¡¼Ó±â(àÊû¡Ê¥áÜѦ)
  • acute serum
    ±Þä Ç÷û(Ðáóõúìôè)
  • antilymphocyte serum
    Ç×Àӯı¸Ç÷û(ù÷×ú÷éϹúìôè)
  • blood serum
    Ç÷û(úìôè)
  • immune serum
    ¸é¿ª Ç÷û(Øóæ¹úìôè)
  • serum
    Ç÷û(úìôè)
  • serum Ac globulin
    Ç÷û(úìôè) Ac±Û·ÎºÒ¸°
  • serum albumin
    Ç÷û(úìôè) ¾ËºÎ¹Î
  • serum converting enzyme
    Ç÷û Àüȯ È¿¼Ò(úìôèï®üµý£áÈ)
  • serum folate
    Ç÷û(úìôè) Æú»ê(ß«)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • thrombotic infarct
    Ç÷Àü¼º°æ»ö
  • radioiodinated serum albumin
    ¹æ»ç¼±¿ä¿ÀµåÈ­Ç÷û¾ËºÎ¹Î
  • serum
    Ç÷û
  • serum amylase
    Ç÷û¾Æ¹Ð¶ó¾ÆÁ¦
  • serum creatinine
    Ç÷ûũ·¹¾ÆÆ¼´Ñ
  • serum protein
    Ç÷û´Ü¹é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
STA second trimester abortion; serum thrombotic accelerator; superficial temporal artery
PPCA plasma prothrombin conversion accelerator; proserum prothrombin conversion accelerator
SAF scrapie-associated fibrils; self-articulating femoral; serum accelerator factor; simultaneous audito...
SPCA serum prothrombin conversion accelerator; Society for Prevention of Cruelty to Animals
ATS Achard-Thiers syndrome; acid test solution; alpha-D-tocopherol acid succinate; American Thoracic Soc...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AMS Accelerator Mass Spectrometry
LINAC Linear Accelerator
NBTE Non-bacterial thrombotic endocarditis
PTS Post-thrombotic syndrome
TTP Thrombotic Thrombocytopenic Purpura
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • thrombotic infarct
    Ç÷Àü¼º °æ»ö
    ÇüÀüÁõ¿¡ ÀÇÇØ¼­ ¹ß»ýÇÏ´Â °æÁ÷ Çö»ó.
  • accelerator
    ÃËÁø ÀÎÀÚ, ÃËÁøÁ¦, ÃËÁø ¹°Áú, ÃËÁø½Å°æ, Ȱ¼ºÁ¦
    1. ¹°Ã¼ÀÇ ÁøÇà, ¹°ÁúÀÇ È°µ¿ ¶Ç´Â ¾î¶² ¹ÝÀÀÀÌ ÀϾ´Â ¼Óµµ¸¦ Áõ°¡½Ã۱â À§Çؼ­ »ç¿ëµÇ´Â ¹°ÁúÀ̳ª ÀåÄ¡. 2. ±â´ÉÀÇ ¼öÇàÀ» ºü¸£°Ô ÇÏ´Â ½Å°æÀ̳ª ±ÙÀ°. 3. °í¹«ÀÇ °æÈ­ ¶Ç´Â ±× ¿ÜÀÇ ÁßÇÕ¿¡ »ç¿ëµÇ´Â ÀÏ·ÃÀÇ È­ÇÐ ¹°Áú·Î¼­ ÀÛ¾÷ÀÚ¿¡°Ô ÇǺο°À» ÀÚÁÖ ÀÏÀ¸Å²´Ù. 4. È­ÇйÝÀÀÀ» °¡¼ÓÈ­½ÃŰ´Â ¹°Áú 5. »ý¸®ÇÐÀûÀ¸·Î ¿îµ¿À̳ª ¹ÝÀÀÀ» ºü¸£°Ô ÇÏ´Â ½Å°æ, ±ÙÀ°, ȤÀº ¹°Áú. 6. Àú¿Â¿¡¼­ ÁßÇÕÀ» °³½Ã½ÃŰ´Â ÀÛ¿ëÀ» °®´Â ¹°Áú. ÁßÇÕÃ˸Š¶Ç´Â ÃËÁøÁ¦¶ó°íµµ ÇÑ´Ù. 7. ¹ÝÀÀÀ» ´õ¿í ÃËÁøÇϱâ À§ÇÑ ¾àÁ¦.
  • ultra-accelerator
    ÃÊÃËÁøÁ¦
  • acute phase serum
    ±Þ¼º º´±â Ç÷û
  • acute serum sickness
    ±Þ¼º Ç÷ûº´
    Àü½Å¼º ¸é¿ªº¹ÇÕü ÁúȯÀÇ ÀüÇüÀûÀÎ ¿¹ÀÌ´Ù. Çѵ¿¾È Çǵ¿¼º ¸é¿ªÀ» À§ÇØ »ç¿ëµÈ ´Ù·®ÀÇ ÀÌÁ¾ Ç÷ûÀÇ Åõ¿©¿¡ µû¸¥ ÈÄÀ¯ÁõÀÌ´Ù.
  • Banzhaf serum
    ¹ÝÃ÷ÇÏÇÁ Ç÷û
    ³óÃà Ç×Æó¿°±Õ Ç÷û.
  • Bardel's serum
    ¹Ù¾Æµ¨ Ç÷û
  • blood serum
    Ç÷û
    1. Ç÷¾×ÀÌ ¿ÏÀüÈ÷ ÀÀ°íµÈ ´ÙÀ½ Ç÷¾×¿¡¼­ À¯¸®µÈ Åõ¸íÇÑ ¾×ü·Î, ÀÀ°í °úÁ¤¿¡ À־ Ç÷ÀåÀ¸·ÎºÎÅÍ ¼¶À¯¼Ò¿øÀÌ Á¦°ÅµÈ °Í. 2. Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¿øÀ» Á¦°ÅÇÑ ³ª¸ÓÁö. »ýü¿¡¼­ äÃëÇÑ Ç÷¾×À» ½ÃÇè°ü¿¡ ³Ö¾î Á¶¿ëÈ÷ ¼¼¿öµÎ¸é ¸ÕÀú ÀÀ°íÇÏ¿© ÀÀÇ÷ÀÌ µÇ°í, À̰ÍÀÌ ¼öÃàÇÏ¿© ¾ÏÀû»öÀÇ µ¢¾î¸®ÀÎ Ç÷º´°ú ´ãȲ»öÀÇ Åõ¸íÇÑ ¾×üÀÎ Ç÷ûÀ¸·Î ³ª´©¾îÁø´Ù. Áï, Ç÷¾×¿¡¼­ À¯Çü ¼ººÐ ÀÌ¿ÜÀÇ ºÎºÐÀº Ç÷ÀåÀε¥, ÀÌ Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¿ø
  • foreign serum
    ÀÌÁ¾ Ç÷û
  • horse serum
    ¸» Ç÷û
    ¸»ÀÇ Ç÷¾×¿¡¼­ ¾ò¾îÁö´Â Ç÷û.
  • human serum immune globulin
    Àΰ£ Ç÷û ¸é¿ª ±Û·ÎºÒ¸°
  • immune serum
    ¸é¿ª Ç÷û
    ¾î¶² Ç׿ø¿¡ ´ëÇÑ Æ¯ÀÌÀû Ç×ü¸¦ ÇÔÀ¯Çϰí ÀÖ´Â Ç÷û. Ç×Ç÷ûÀ̶ó°íµµ ÇÑ´Ù. Áúº´ Ä¡·á
  • immune serum globulin
    ¸é¿ª Ç÷û ±Û·ÎºÒ¸°
  • Luton's serum
    ·çÅæ Ç÷û
  • polyvalent serum
    ´Ù°¡ Ç÷û
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
serum accelerator <chemical> Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor viia in the extrinsic pathway of blood coagulation. The activated form then catalyses the activation of factor x to factor xa.
Chemical name: Blood-coagulation factor VII
(12 Dec 1998)
serum accelerator globulin A substance in serum that accelerates the conversion of prothrombin to thrombin in the presence of thromboplastin and calcium; produced by the action of traces of thrombin upon plasma accelerator globulin.
(05 Mar 2000)
serum prothrombin conversion accelerator <chemical> Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor viia in the extrinsic pathway of blood coagulation. The activated form then catalyses the activation of factor x to factor xa.
Chemical name: Blood-coagulation factor VII
(12 Dec 1998)
abacterial thrombotic endocarditis Verrucous endocardial lesions occurring in the terminal stages of many chronic infectious and wasting diseases.
Synonym: abacterial thrombotic endocarditis, cachectic endocarditis, terminal endocarditis, thromboendocarditis.
(05 Mar 2000)
purpura, thrombotic thrombocytopenic A disease characterised by thrombocytopenia, haemolytic anaemia, bizarre neurological manifestations, azotemia, fever, and thromboses in terminal arterioles and capillaries.
(12 Dec 1998)
nonbacterial thrombotic endocarditis Verrucous endocardial lesions occurring in the terminal stages of many chronic infectious and wasting diseases.
Synonym: abacterial thrombotic endocarditis, cachectic endocarditis, terminal endocarditis, thromboendocarditis.
(05 Mar 2000)
thrombotic Relating to, caused by, or characterised by thrombosis.
(05 Mar 2000)
thrombotic disease due to protein c deficiency Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein c results in thrombotic (clotting) disease and excess platelets with recurrent thrombophlebitis (inflammation of the vein that occurs when a clot forms). The clot can break loose and travel through the blood stream (thromboembolism) to the lungs causing a pulmonary embolism, brain causing a stroke (cerebrovascular accident), heart causing an early heart attack, skin causing what in the newborn is called neonatal purpura fulminans, the adrenal gland causing haemorrhage with abdominal pain, abnormally low blood pressure (hypotension), and salt loss. Protein c deficiency is due to possession of one gene (heterozygosity) in chromosome band 2q13-14. The possession of two such genes (homozygosity) is usually lethal.
(12 Dec 1998)
thrombotic gangrene Gangrene due to occlusion of an artery by a thrombus.
(05 Mar 2000)
thrombotic hydrocephalus Increase in cerebrospinal fluid and of intracranial pressure following thrombosis of the cerebral veins or sinuses; caused by septic infection, dehydration, tuberculosis, typhoid, leukaemia, and other conditions.
(05 Mar 2000)
thrombotic infarct An infarct caused by a thrombus.
(05 Mar 2000)
thrombotic microangiopathy Thrombosis within small blood vessels, as in thrombotic thrombocytopenic purpura.
(05 Mar 2000)
thrombotic phlegmasia An extreme edematous swelling of the leg following childbirth, due to thrombosis of the iliofemoral veins.
Synonym: leukophlegmasia dolens, milk leg, puerperal phlebitis, thrombotic phlegmasia, white leg.
(05 Mar 2000)
thrombotic thrombocytopenic purpura A rapidly fatal or occasionally protracted disease with varied symptoms in addition to purpura, including signs of central nervous system involvement, due to formation of fibrin or platelet thrombi in arterioles and capillaries in many organs.
Synonym: Moschcowitz' disease.
(05 Mar 2000)
accelerator 1. Anything that increases rapidity of action or function.
2. In physiology, a nerve, muscle, or substance that quickens movement or response.
3. A catalytic agent used to hasten a chemical reaction.
4. In nuclear physics, a device that accelerates charged particles (e.g., protons) to high speed in order to produce nuclear reactions in a target, often for the production of radionuclides or for radiation therapy.
Synonym: accelerant.
Origin: L. Accelerans, pres. P. Of ac-celero, to hasten, fr. Celer, swift
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • serum
    Ç÷û
  • immune serum
    ¸é¿ª Ç÷û
  • serum
    Àå¾×;Ç÷û
  • truth serum
    Áø½É Åä·Î¾à (¸ÔÀ¸¸é Áø½ÉÀ» Åоî³õ´Â´Ù´Â ¾à)
  • accelerator
    °¡¼ÓÀÚ
  • accelerator
    °¡¼ÓÀåÄ¡;ÃËÁøÁ¦
  • induction accelerator
    BETATRON
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • particle accelerator
    ÀÔÀÚ °¡¼Ó±â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á